Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of prostaglandin synthesis in prostate cancer.

× No keyword cloud information.

16 in total

Review 1. Vitamin D and cancer: a review of molecular mechanisms.

Authors: James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal: Biochem J Date: 2012-01-01 Impact factor: 3.857

2. Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells.

Authors: Ana Belén Fernández-Martínez; Javier Lucio-Cazaña
Journal: Cell Mol Life Sci Date: 2015-04-01 Impact factor: 9.261

3. Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.

Authors: Preet K Dhillon; Stacey A Kenfield; Meir J Stampfer; Edward L Giovannucci
Journal: Int J Cancer Date: 2011-02-26 Impact factor: 7.396

4. Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.

Authors: Jun Yu; Alex Y Hui; Eagle S H Chu; Alfred S L Cheng; Minnie Y Y Go; Henry L Y Chan; Wai K Leung; Kin F Cheung; Arthur K K Ching; Yiu L Chui; Ka K Chan; Joseph J Y Sung
Journal: Gut Date: 2006-12-05 Impact factor: 23.059

Review 5. ERG expression in prostate cancer: biological relevance and clinical implication.

Authors: Hatem Abou-Ouf; Liena Zhao; Tarek A Bismar
Journal: J Cancer Res Clin Oncol Date: 2015-12-28 Impact factor: 4.553

6. Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.

Authors: Adriana C Vidal; Lauren E Howard; Daniel M Moreira; Ramiro Castro-Santamaria; Gerald L Andriole; Stephen J Freedland
Journal: Clin Cancer Res Date: 2014-12-17 Impact factor: 12.531

Review 7. Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.

Authors: Anna Alexanian; Andrey Sorokin
Journal: Physiol Genomics Date: 2017-09-22 Impact factor: 3.107

8. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.

Authors: Erika M Kwon; Claudia A Salinas; Suzanne Kolb; Rong Fu; Ziding Feng; Janet L Stanford; Elaine A Ostrander
Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-03-23 Impact factor: 4.254

9. Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.

Authors: Srilatha Swami; Aruna V Krishnan; Jacqueline Moreno; Rumi S Bhattacharyya; Christopher Gardner; James D Brooks; Donna M Peehl; David Feldman
Journal: Int J Cancer Date: 2009-05-01 Impact factor: 7.396

10. Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer.

Authors: Aruna V Krishnan; Sandy Srinivas; David Feldman
Journal: Dermatoendocrinol Date: 2009-01